Alectinib-induced hemolytic anemia von Lee, Chung-Shien, Sullivan, Kevin

Volltext

Inpatient utilization of immune checkpoint inhibitors and clinical outcomes von Wang, Jonathan, Lee, Chung-Shien, Attarian, Shirin, Kohn, Nina, Devoe, Craig

Volltext

An Overview of the Changing Landscape of Treatment for Advanced Melanoma von Lee, Chung‐Shien, Thomas, Christan M., Ng, Kimberly E.

Volltext

A deep dive into CDK4/6 inhibitors: Evaluating real world toxicities and treatment paradigms in the elderly population von Olazagasti, Coral, Lee, Chung-Shien, Liu, Angel, Stefanov, Dimitre, Cheng, Kit

Volltext

Lorlatinib induced proteinuria: A case report von Lee, Chung-Shien, Wanchoo, Rimda, Seetharamu, Nagashree

Volltext

A real world analysis of first line treatment of advanced EGFR mutated non-small cell lung cancer: A multi-center, retrospective study von Lee, Chung-Shien, Ahmed, Iman, Miao, Emily, Chung, Shirley, Patel, Khilna, Kohn, Nina, Seetharamu, Nagashree

Volltext

A contemporary review of rearranged during transfection-selective inhibitors von Liu, Angel W, Liang, Connie, Lee, Chung-Shien

Volltext

A Real World Perspective of PARP Inhibitor Use in Gynecological Cancer Patients von Lee, Chung-Shien, Hernandez, Jennifer, Liang, Connie, Leung, Ashley, Stefanov, Dimitre G., Cheng, Kit, John, Veena

Volltext

Clinical efficacy with dabrafenib and trametinib in a T599_V600insT poorly differentiated metastatic thyroid carcinoma von Lee, Chung-Shien, Miao, Emily, Das, Kasturi, Seetharamu, Nagashree

Volltext

A retrospective analysis of tumor lysis syndrome management in a quaternary care hospital von Eng, Stephen, Lee, Chung-Shien, Ahn, Seungjun, Sharma, Amy

Volltext

Pemetrexed-induced severe rhabdomyolysis in lung cancer: A case report von Sullivan, Kevin, Lee, Chung-Shien

Volltext

Osimertinib in EGFR-Mutated Lung Cancer: A Review of the Existing and Emerging Clinical Data von Lee, Chung-Shien, Milone, Matthew, Seetharamu, Nagashree

Volltext

Penetrating the evidence of EGFR and ALK tyrosine kinase inhibitors for non-small cell lung cancer brain metastases von Thomas, Christan M, Lee, Chung-Shien

Volltext

A Retrospective Study of the Effect of Metformin on Patients with Metastatic Prostate Cancer von Lee, Chung-Shien, Lam, So Yi, Liu, Angel, Sison, Cristina, Zhu, Xin-Hua

Volltext

Epidemiology and clinicopathological features of lung cancer in patients with prior history of breast cancer von Wang, Kevin Y, Newman, James, Lee, Chung-Shien, Seetharamu, Nagashree

Volltext

Safety and Efficacy of Immune Checkpoint Inhibitors in Cancer Patients and Preexisting Autoimmune Disease: A Systematic Review and Meta-Analysis in Non–Small-Cell Lung Cancer von Aung, Wint Yan, Lee, Chung-Shien, Morales, Jaclyn, Rahman, Husneara, Seetharamu, Nagashree

Volltext

A Comprehensive Review of Contemporary Literature for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer and Their Toxicity von Lee, Chung-Shien, Sharma, Sandhya, Miao, Emily, Mensah, Cheryl, Sullivan, Kevin, Seetharamu, Nagashree

Volltext

Characteristics of Patients With Second Primary Lung Cancer Following Breast Cancer: A Retrospective Descriptive Study von Wang, Kevin Yu, Lee, Chung-Shien, Vempati, Prashant, Sharma, Rajiv, Kohn, Nina, Seetharamu, Nagashree

Volltext

The emerging landscape of EFGR tyrosine kinase inhibitors in lung adenocarcinoma—successes and challenges von Oduah, Eziafa I., Lee, Chung-Shien, Seetharamu, Nagarashee

Volltext

Impact of Tyrosine Kinase Inhibitor Starting Dose on Outcomes in Patients With Non-Small Cell Lung Cancer von Miao, Emily, Seetharamu, Nagashree, Sullivan, Kevin, Eng, Stephen, Lee, Chung-Shien

Volltext